Modulation of the antidepressant-like effects of sustained administration of carisbamate and lamotrigine on monoaminergic systems: Electrophysiological studies in the Rat Brain

Journal of Pharmacology and Experimental Therapeutics

Volumn 347, Issue 2, 2013, Pages 487-496

  Shim, Stacey ^a   El Mansari, Mostafa ^a   Blier, Pierre ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; AUTORECEPTOR; CARISBAMATE; DOPAMINE; LAMOTRIGINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NORADRENALIN; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B AUTORECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; FORCED SWIMMING TEST; FOREBRAIN; HIPPOCAMPAL CA3 REGION; IN VIVO STUDY; LOCUS CERULEUS; MALE; MONOAMINERGIC SYSTEM; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; RAT; RECEPTOR DOWN REGULATION; SEROTONINERGIC TRANSMISSION; TREATMENT DURATION; VENTRAL TEGMENTUM;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; BRAIN; CA3 REGION, HIPPOCAMPAL; CARBAMATES; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCUS COERULEUS; MALE; NEURONS; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC POTENTIALS; TRIAZINES; VENTRAL TEGMENTAL AREA;

EID: 84886043754     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.203315     Document Type: Article

References (53)

1. Ahmad S, Fowler LJ, and Whitton PS (2004) Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat. Br J Pharmacol 142:136-142.
2. Barbee JG, Thompson TR, Jamhour N.J., Stewart JW, Conrad EJ, Reimherr FW, Thompson P.M., and Shelton RC (2011) A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression. J Clin Psychiatry 72:1405-1412.
3. Barbosa L, Berk M, and Vorster M (2003) A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. J Clin Psychiatry 64:403-407.
4. Besson A, Haddjeri N, Blier P., and de Montigny C (2000) Effects of the coadministration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain. Eur Neuropsychopharmacol 10:177-188.
5. Bourin M, Chenu F, and Hascoët M (2009) The role of sodium channels in the mechanism of action of antidepressants and mood stabilizers. Curr Drug Targets 10:1052-1060.
6. Bourin M, Masse F, and Hascoët M (2005) Evidence for the activity of lamotrigine at 5-HT(1A) receptors in the mouse forced swimming test. J Psychiatry Neurosci 30: 275-282.
7. Bunney WE, Jr, Brodie HK, Murphy DL, and Goodwin FK (1971) Studies of alpha-methyl-para-tyrosine, L-dopa, and L-tryptophan in depression and mania. Am J Psychiatry 127:872-881.
8. Calabrese JR, Bowden CL, Sachs G.S., Ascher JA, Monaghan E, and Rudd GD (1999) A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 60:79-88.
9. (A), and glutamate receptors. J Neurosci 21:9917-9929.
10. Chaput Y, Blier P, and de Montigny C (1986) In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J Neurosci 6: 2796-2801.
11. Chernoloz O, El Mansari M, and Blier P (2012) Effects of sustained administration of quetiapine alone and in combination with a serotonin reuptake inhibitor on norepinephrine and serotonin transmission. Neuropsychopharmacology 37:1717-1728.
12. Codagnone FT, Consoni FT, Rodrigues A.L., Vital MA, and Andreatini R (2007) Veratrine blocks the lamotrigine-induced swimming increase and immobility decrease in the modified forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 31:1307-1311.
13. Consoni FT, Vital MA, and Andreatini R (2006) Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test. Eur Neuropsychopharmacol 16:451-458.
14. Cramer JA, Blum D, Reed M., and Fanning K; Epilepsy Impact Project Group (2003) The influence of comorbid depression on seizure severity. Epilepsia 44:1578-1584.
15. Dawe GS, Huff KD, Vandergriff J.L., Sharp T., O'Neill MJ, and Rasmussen K (2001) Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity. Biol Psychiatry 50:510-520.
16. de Montigny C and Aghajanian GK (1978) Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202: 1303-1306.
17. de Montigny C., Wang RY, Reader T.A., and Aghajanian GK (1980) Monoaminergic denervation of the rat hippocampus: microiontophoretic studies on pre- and postsynaptic supersensitivity to norepinephrine and serotonin. Brain Res 200:363-376.
18. de Montigny C (1984) Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin. J Pharmacol Exp Ther 228:230-234.
19. Dremencov E, El Mansari M, and Blier P (2009) Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area. J Psychiatry Neurosci 34:223-229.
20. François J., Germe K, Ferrandon A., Koning E, and Nehlig A (2011) Carisbamate has powerful disease-modifying effects in the lithium-pilocarpine model of temporal lobe epilepsy. Neuropharmacology 61:313-328.
21. Freeman AS, Meltzer LT, and Bunney BS (1985) Firing properties of substantia nigra dopaminergic neurons in freely moving rats. Life Sci 36:1983-1994.
22. Ghanbari R, El Mansari M, and Blier P (2011) Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion. Psychopharmacology (Berl) 217:61-73.
23. Goldin AL (2001) Resurgence of sodium channel research. Annu Rev Physiol 63: 871-894.
24. Grace AA and Bunney BS (1983) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons - 1. Identification and characterization. Neuroscience 10:301-315.
25. Haddjeri N, Blier P, and de Montigny C (1998) Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci 18: 10150-10156.
26. Haddjeri N, Lavoie N, and Blier P (2004) Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus. Neuropsychopharmacology 29:1800-1806.
27. Hajós M and Sharp T (1996) Burst-firing activity of presumed 5-HT neurones of the rat dorsal raphe nucleus: electrophysiological analysis by antidromic stimulation. Brain Res 740:162-168.
28. Jobe PC, Dailey JW, and Wernicke JF (1999) A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev Neurobiol 13:317-356.
29. Joel D, Weiner I, and Feldon J (1997) Electrolytic lesions of the medial prefrontal cortex in rats disrupt performance on an analog of the Wisconsin Card Sorting Test, but do not disrupt latent inhibition: implications for animal models of schizophrenia. Behav Brain Res 85:187-201.
30. Kuo CC and Lu L (1997) Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones. Br J Pharmacol 121:1231-1238.
31. Leach MJ, Marden CM, and Miller AA (1986) Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 27:490-497.
32. Lee CY, Fu WM, Chen C.C., Su MJ, and Liou HH (2008) Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia 49: 888-897.
33. Lee CY, Lee ML, Shih C.C., and Liou HH (2011) Carisbamate (RWJ-333369) inhibits glutamate transmission in the granule cell of the dentate gyrus. Neuropharmacology 61:1239-1247.
34. Liu Y, Yohrling GJ, Wang Y, Hutchinson T.L., Brenneman DE, Flores CM, and Zhao B (2009) Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons. Epilepsy Res 83: 66-72.
35. Lizasoain I, Knowles RG, and Moncada S (1995) Inhibition by lamotrigine of the generation of nitric oxide in rat forebrain slices. J Neurochem 64:636-642.
36. Manta S, El Mansari M, Debonnel G, Blier P. (2013) Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems. Int J Neuropsychopharmacol 16:459-470.
37. Mazarati A, Siddarth P, Baldwin R.A., Shin D., Caplan R, and Sankar R (2008) Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain 131:2071-2083.
38. Normann C, Hummel B, Schärer LO, Hörn M, Grunze H., and Walden J (2002) Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study. J Clin Psychiatry 63:337-344.
39. Page ME, Detke MJ, Dalvi A, Kirby L.G., and Lucki I (1999) Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) 147:162-167 berl.
40. Pan ZZ and Williams JT (1989) GABA- and glutamate-mediated synaptic potentials in rat dorsal raphe neurons in vitro. J Neurophysiol 61:719-726.
41. Pineda EA, Hensler JG, Sankar R, Shin D., Burke TF, and Mazarati AM (2011) Plasticity of presynaptic and postsynaptic serotonin 1A receptors in an animal model of epilepsy-associated depression. Neuropsychopharmacology 36:1305-1316.
42. Piñeyro G and Blier P (1999) Autoregulation of serotonin neurons: role in antide-pressant drug action. Pharmacol Rev 51:533-591.
43. Quarta D and Large CH (2011) Effects of lamotrigine on PCP-evoked elevations in monoamine levels in the medial prefrontal cortex of freely moving rats. J Psychopharmacol 25:1703-1711.
44. Reid JG, Gitlin MJ, and Altshuler LL (2013) Lamotrigine in Psychiatric disorders. J Clin Psychiatry 74:675-684.
45. Rogawski MA (2006) Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res 69:273-294.
46. Sanacora G, Treccani G, and Popoli M (2012) Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62:63-77.
47. Schlaepfer TE, Frick C, Zobel A., Maier, Heuser I, Bajbouj M, O'Keane V, Corcoran C, Adolfsson R, Trimble M, et al. (2008) Vagus nerve stimulation for depression: efficacy and safety in a European study [published correction appears in Psychol Med (2008) 38:1067]. Psychol Med 38:651-661.
48. Southam E, Kirkby D, Higgins G.A., and Hagan RM (1998) Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats. Eur J Pharmacol 358:19-24.
49. Szabo ST, de Montigny C, and Blier P (2000) Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors. Int J Neuropsychopharmacol 3:1-11.
50. Tanahashi S, Yamamura S, Nakagawa M., Motomura E, and Okada M (2012) Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus. Psychopharmacology (Berl) 220:599-610.
51. Tao R, Ma Z, and Auerbach SB (1997) Influence of AMPA/kainate receptors on extracellular 5-hydroxytryptamine in rat midbrain raphe and forebrain. Br J Pharmacol 121:1707-1715.
52. Ungless MA and Grace AA (2012) Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci 35:422-430.
53. + channels in rat hippocampal neurones. Pflugers Arch 430:437-446.